A comparative study on the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension

被引:7
作者
Hamada, Toshihiro [1 ]
Kuwabara, Masanari [2 ]
Watanabe, Arisa [1 ]
Mizuta, Einosuke [3 ]
Ohtahara, Akira [3 ]
Omodani, Hiroki [4 ]
Watanabe, Masashi [5 ]
Nakamura, Hiroki [6 ]
Hirota, Yutaka [7 ]
Miyazaki, Satoshi [8 ]
Kato, Masahiko [9 ]
Ogino, Kazuhide [10 ]
Kosaka, Hiroki [11 ]
Haruaki, Ninomiya [12 ]
Taniguchi, Shin-ichi [1 ]
Yamamoto, Kazuhiro [9 ]
Kotake, Hiroshi [13 ]
Hisatome, Ichiro [2 ]
机构
[1] Tottori Univ, Fac Med, Dept Reg Med, Yonago, Tottori 6838503, Japan
[2] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut, Yonago, Tottori 6838503, Japan
[3] Sanin Rosai Hosp, Dept Cardiovasc Med, Yonago, Tottori, Japan
[4] Omodani Clin, Div Cardiovasc Med, Yonago, Tottori, Japan
[5] Watanabe Clin, Div Cardiovasc Med, Sakaiminato, Japan
[6] Nakamura Clin, Tottori, Japan
[7] Tomimasu Surg & Primary Care Clin, Yonago, Tottori, Japan
[8] Nojima Hosp, Div Cardiol, Kurayoshi, Japan
[9] Tottori Univ, Fac Med, Div Mol Med & Therapeut, Yonago, Tottori 6838503, Japan
[10] Tottori Univ Hosp, Ctr Clin Residency Program, Yonago, Tottori, Japan
[11] Tottori Red Cross Hosp, Div Internal Med, Tottori, Japan
[12] Tottori Univ, Fac Med, Dept Biochem Regulat, Yonago, Tottori 6838503, Japan
[13] Kotake Clin, Div Cardiovasc Med, Yonago, Tottori, Japan
关键词
HOMA-R; hydrochlorothiazide; losartan; serum uric acid; telmisartan; URIC-ACID; URATE LEVELS; BENZBROMARONE; COMBINATION; LOSARTAN; THERAPY;
D O I
10.3109/10641963.2013.810228
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: Long-term effects of a low-dose hydrochlorothiazide (HCTZ) with losartan (LOS) on uric acid (UA) metabolism as well as glucose metabolism have been studied in hypertensive patients in comparison with those of a low-dose HCTZ with telmisartan (TEL). Method: Fifty-nine hypertensive patients were allocated to a combination therapy with either losartan (50 mg/day)/HCTZ (12.5 mg/day) (LOS + HCTZ group: n = 37) or telmisartan (40 mg/day)/HCTZ (12.5 mg/day) (TEL + HCTZ group: n = 22), respectively. Before and 1 year after the treatment, blood pressure and biochemical parameters of blood and urine were evaluated. Results: Both systolic and diastolic blood pressures significantly decreased in two groups, without any statistical differences among them. LOS + HCTZ caused no changes in the serum UA level or the ratio of UA clearance to creatinine clearance (CUA/Ccr), whereas TEL + HCTZ significantly increased the serum UA level and reduced CUA/Ccr. LOS + HCTZ did not influence CUA/Ccr in patients with their serum UA below 5.4 mg/dl, while LOS + HCTZ significantly increased CUA/Ccr in patients with their serum UA above 5.5 mg/dl. TEL + HCTZ significantly reduced CUA/Ccr in patients with their serum UA below and above 5.4 mg/dl to increase serum UA level significantly. Neither combination therapies caused any changes in fasting plasma glucose, HbA1c and HOMA-R. In patients with their serum UA level above 5.4 mg/dl, TEL + HCTZ increased HOMA-R, whereas LOS + HCTZ did not. Conclusions: LOS + HCTZ did not influence UA metabolism as well as glucose metabolism, likely because of inhibitory action of losartan on URAT1, although TEL + HCTZ were accompanied with impairment of the UA metabolism and glucose metabolism.
引用
收藏
页码:251 / 257
页数:7
相关论文
共 16 条
[11]   Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure A Double-Blind Placebo-Controlled Crossover Preliminary Study [J].
Ogino, Kazuhide ;
Kato, Masahiko ;
Furuse, Yoshiyuki ;
Kinugasa, Yoshiharu ;
Ishida, Katsunori ;
Osaki, Shuichi ;
Kinugawa, Toru ;
Igawa, Osamu ;
Hisatome, Ichiro ;
Shigemasa, Chiaki ;
Anker, Stefan D. ;
Doehner, Wolfram .
CIRCULATION-HEART FAILURE, 2010, 3 (01) :73-81
[12]   The kidney: An unwilling accomplice in syndrome X [J].
Reaven, GM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (06) :928-931
[13]   Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake [J].
Roncal-Jimenez, Carlos A. ;
Lanaspa, Miguel A. ;
Rivard, Christopher J. ;
Nakagawa, Takahiko ;
Gabriela Sanchez-Lozada, L. ;
Jalal, Diana ;
Andres-Hernando, Ana ;
Tanabe, Katsuyuki ;
Madero, Magdalena ;
Li, Nanxing ;
Cicerchi, Christina ;
Mc Fann, Kim ;
Sautin, Yuri Y. ;
Johnson, Richard J. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (09) :1259-1270
[14]   Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress [J].
Sautin, Yuri Y. ;
Nakagawa, Takahiko ;
Zharikov, Sergey ;
Johnson, Richard J. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (02) :C584-C596
[15]  
Tsuchihashi Takuya, 2009, Nihon Rinsho, V67, P1439
[16]   Thiazide diuretics, potassium, and the development of diabetes - A quantitative review [J].
Zillich, Alan J. ;
Garg, Jay ;
Basu, Sanjib ;
Bakris, George L. ;
Carter, Barry L. .
HYPERTENSION, 2006, 48 (02) :219-224